Analyzes vitamin D level impact on pain characteristics and duration in postherpetic neuralgia patients, suggesting clinical significance.
BACKGROUND: Aim is to analyze the correlation between plasma vitamin D (VD) level and pain characteristics and duration in patients with postherpetic neuralgia (PHN). METHODS: 116 patients with PHN were prospectively collected as the PHN group, and another 102 non-PHN patients were selected as the control group. The plasma VD levels were detected by enzyme-linked immunosorbent assay. The factors affecting the plasma VD levels of PHN patients were analyzed by one-way and logistic regression analysis. The correlation between the plasma VD levels of the PHN patients with pain characteristics and duration was analyzed by Pearson correlation. RESULTS: Plasma VD levels [(26.63 ± 2.95) ng/mL] in patients in the PHN group were significantly lower compared with those in the control group [(31.39 ± 2.98) ng/mL] (p < 0.001). Plasma VD level was associated with LANSS score (OR = 1.302), pain type (OR = 3.218) and pain duration (OR = 1.392) in patients with PHN (all p < 0.01). Plasma VD levels were negatively correlated with LANSS score (r = -0.346) and pain duration (r =- 0.381) in patients with PHN. CONCLUSIONS: Plasma VD levels are significantly lower in patients with PHN, and plasma VD levels determine pain characteristics and duration.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: